Table 2.
Study | Blinding | HA Characteristics | Follow-up (Days) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Subjects | Injectors | Outcome Assessors | Trade Name | US Approved | Cross-Linked | Avian Origin | MW (kDa) | No. Injections | ||
Altman, 1998 34 | Yes | No | No | HYALGAN | Yes | No | Yes | 730 | 5 | 182 |
Altman, 2004 35 | Yes | No | Yes | DUROLANE | Yes | Yes | No | 9000 | 1 | 182 |
Altman, 2009 36 | Yes | No | Yes | EUFLEXXA | Yes | No | No | 3600 | 3 | 182 |
Arden, 2014 37 | Yes | No | Yes | DUROLANE | Yes | Yes | No | 9000 | 1 | 42 |
Baltzer, 2009 38 | Yes | No | Yes | HYA-JECT | No | No | No | 1400 | 3 | 203 |
Brandt, 2001 26 | Yes | No | Yes | ORTHOVISC | Yes | No | No | 2900 | 3 | 189 |
Chevalier, 2010 39 | Yes | No | Yes | SYNVISC | Yes | Yes | Yes | 6000 | 1 | 182 |
Day, 2004 40 | Yes | No | Yes | ARTZAL | Yes | No | Yes | 1170 | 5 | 126 |
Dickson, 2001 41 | Yes | No | Yes | SYNVISC | Yes | Yes | Yes | 6000 | 3 | 84 |
Dixon, 1988 25 | Yes | No | Yes | HYALGAN | Yes | No | Yes | 730 | 11 | 336 |
Dougados, 1993 42 | No | No | No | HYALGAN | Yes | No | Yes | 730 | 4 | 364 |
Hangody, 2017 43 | Yes | Yes | Yes | MONOVISC | Yes | Yes | No | 2900 | 1 | 182 |
Henderson, 1994 44 | Yes | No | Yes | HYALGAN | Yes | No | Yes | 730 | 5 | 35 |
Henrotin, 2017 45 | Yes | Yes | Yes | KARTILAGE CROSS | No | No | No | a | 1 | 180 |
Huang, 2011 46 | Yes | No | Yes | HYALGAN | Yes | No | Yes | 730 | 5 | 175 |
Huskisson, 1999 47 | Yes | No | Yes | HYALGAN | Yes | No | Yes | 730 | 5 | 182 |
Jorgensen, 2010 48 | Yes | No | Yes | HYALGAN | Yes | No | Yes | 730 | 5 | 91 |
Karlsson, 2002a 49 | Yes | No | Yes | ARTZAL | Yes | No | Yes | 1170 | 3 | 182 |
Karlsson, 2002b 49 | Yes | No | Yes | SYNVISC | Yes | Yes | Yes | 6000 | 3 | 182 |
Kosuwon, 2012 50 | Yes | No | Yes | GO-ON | No | No | No | 1500 | 5 | 182 |
Lohmander, 1996 27 | Yes | No | Yes | ARTZAL | Yes | No | Yes | 1170 | 5 | 185 |
Lundsgaard, 2008 51 | Yes | No | Yes | HYALGAN | Yes | No | Yes | 730 | 4 | 182 |
Neustadt, 2005 52 | Yes | No | Yes | ORTHOVISC | Yes | No | No | 2900 | 4 | 196 |
Petrella, 2002 53 | Yes | Yes | Yes | SUPLASYN | No | Yes | No | 1000 | 3 | 84 |
Petrella, 2006 54 | Yes | No | Yes | SUPLASYN | No | Yes | No | 1000 | 3 | 84 |
Petrella, 2008a 55 | Yes | No | No | HYALGAN | Yes | No | Yes | 730 | 3 | 728 |
Petrella, 2008b 55 | Yes | No | No | SYNVISC | Yes | Yes | Yes | 6000 | 3 | 728 |
Petterson, 2018 56 | Yes | Yes | Yes | MONOVISC | Yes | Yes | No | 2900 | 1 | 182 |
Pham, 2004 57 | Yes | No | Yes | NRD101 | No | a | No | 1900 | 3 | 365 |
Puhl, 1993 58 | Yes | No | Yes | ARTZAL | Yes | No | Yes | 1170 | 5 | 98 |
Rolf, 2005a 59 | Yes | No | Yes | SYNVISC | Yes | Yes | Yes | 6000 | 3 | 364 |
Rolf, 2005b 59 | Yes | No | Yes | ARTZAL | Yes | No | Yes | 1170 | 3 | 364 |
Saravanan, 2002 60 | No | No | No | SYNVISC | Yes | Yes | Yes | 6000 | 3 | 42 |
Seikagaku, 2001 61 | Yes | No | No | ARTZAL | Yes | No | Yes | 1170 | 3 | 126 |
Shichikawa, 1983 62 | Yes | No | No | NOT REPORTED | No | a | a | a | 5 | 35 |
Strand, 2012 63 | Yes | No | Yes | GEL-ONE | Yes | Yes | Yes | a | 1 | 91 |
Wobig, 1998 64 | Yes | Yes | Yes | SYNVISC | Yes | Yes | Yes | 6000 | 3 | 182 |
Wu, 1997 65 | Yes | No | No | ARTZAL | Yes | No | Yes | 1170 | 5 | 182 |
HA = hyaluronic acid; MW = molecular weight; US = United States.
Values not reported.